Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Igor Puzanov
Adjuvant Sunitinib or Sorafenib for High-Risk, Non-Metastatic Renal-Cell Carcinoma (ECOG-ACRIN E2805): A Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial
The Lancet
Medicine
Melanoma-Specific MHC-II Expression Represents a Tumour-Autonomous Phenotype and Predicts Response to Anti-Pd-1/Pd-L1 Therapy
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Perspectives in Immunotherapy: Meeting Report From the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Long-Term Outcome in BRAFV600E Melanoma Patients Treated With Vemurafenib: Patterns of Disease Progression and Clinical Management of Limited Progression
European Journal of Cancer
Cancer Research
Oncology
Sunitinib-Associated Hypertension and Neutropenia as Efficacy Biomarkers in Metastatic Renal Cell Carcinoma Patients
British Journal of Cancer
Cancer Research
Oncology
Biomarker Analysis of On-Treatment and at Progression Biopsies From BRIM7 - A Phase 1B Trial of Combined Vemurafenib and Cobimetinib Treatment in BRAF V600 Mutated Melanoma
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Perspectives in Melanoma: Meeting Report From the Melanoma Bridge (30 November–2 December, 2017, Naples, Italy)
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Evaluation of the Pharmacokinetic Drug Interaction Potential of Tivantinib (ARQ 197) Using Cocktail Probes in Patients With Advanced Solid Tumours
British Journal of Clinical Pharmacology
Pharmacology
